当前位置:首页 - 行情中心 - 贝瑞基因(000710) - 财务分析 - 利润表

贝瑞基因

(000710)

  

流通市值:58.10亿  总市值:145.39亿
流通股本:1.42亿   总股本:3.55亿

利润表

按照会计年度查询:
报告期2020-09-302020-06-302020-03-312019-12-31
一、营业总收入1,087,765,381.42720,515,704.78369,973,449.871,617,641,301.4
营业收入1,087,765,381.42720,515,704.78369,973,449.871,617,641,301.4
二、营业总成本906,260,513.29582,645,257.03283,554,886.911,174,697,818.69
营业成本516,767,246.9335,027,885.23164,904,983.19628,802,382.96
营业税金及附加5,370,706.394,030,140.82479,466.66,277,860.34
销售费用192,176,317.87118,859,323.2857,419,026.13299,040,471.53
管理费用93,112,710.5461,877,257.3227,660,646.32121,767,231.39
财务费用9,442,539.826,690,586.683,509,976.99-693,123.88
资产减值损失2,950.092,950.09----
三、其他经营收益--5,646,667--7,684,697.04
允许价值变动净收益--------
投资净收益2,060,412.866,084,015.57-13,836,212.0715,112,437.75
联营、合营企业投资收益-28,239,541.49-27,705,600.96-14,737,800-81,011,321.45
汇兑净收益--------
四、营业利润183,400,539.89141,561,373.8871,853,716.53450,186,565.54
营业外收入3,607,324.11,379,713.96709,129.64313,641.26
营业外支出1,911,331.63964,801.24525,856.054,831,772.19
非流动资产处置净损失--------
五、利润总额185,096,532.36141,976,286.672,036,990.12445,668,434.61
所得税38,269,179.1927,487,957.8511,988,649.0758,538,131.94
未确认的投资损失--------
六、净利润(百万元)150.83117.4762.39390.62
少数股东损益-4,004,570.2-2,983,501.42-2,344,957.05-3,487,995.48
归属于母公司股东的净利润150,831,923.37117,471,830.1762,393,298.1390,618,298.15
七、每股收益0.430.330.181.1
基本每股收益0.430.330.181.1
稀释每股收益0.430.330.181.1
TOP↑